Fund shareholders of Innoviva Inc
ISIN US45781M1018 · United States · LEI 549300ACOX4QTBES6535
- Fund shareholders
- 326
- Of which ETFs
- 99 227 other funds
- Value held
- ≈ 787.9M $ 787.8M $ · 105.5K €
- Share of capital
- 47.1 % of 72.2M shares on Jul 31, 2026
| Fund | Shares | Value | Weight in fund | Share of capital | |
|---|---|---|---|---|---|
| PD Small-Cap Value Index Portfolio PACIFIC SELECT FUND | 553 | 12.9K $ | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
| State Street(R) SPDR(R) S&P SmallCap 600 ESG ETF SPDR SERIES TRUST | 550 | 12.8K $ | 0.18 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Harbor AlphaEdge Small Cap Earners ETF Harbor ETF Trust | 456 | 10.5K $ | 0.09 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Knights of Columbus U.S. ALL CAP INDEX FUND ADVISORS' INNER CIRCLE III | 384 | 8.8K $ | 0.00 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Russell 2000 2x Strategy Fund Rydex Dynamic Funds | 367 | 8.6K $ | 0.02 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Small-Cap Equity Portfolio PACIFIC SELECT FUND | 340 | 7.9K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| State Street Balanced Index Fund STATE STREET INSTITUTIONAL INVESTMENT TRUST | 325 | 7.6K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| SmallCap Value Fund II Principal Funds, Inc | 317 | 7.3K $ | 0.00 % | 0.00 % | as of Apr 30, 2026 ↗ |
| PROFUND VP ULTRA SMALL CAP ProFunds | 251 | 5.8K $ | 0.04 % | 0.00 % | as of Mar 31, 2026 ↗ |
| State Street(R) SPDR(R) S&P(R) 1500 Momentum Tilt ETF SPDR SERIES TRUST | 243 | 5.7K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Wilshire 5000 Index Fund Wilshire Mutual Funds Inc | 242 | 5.6K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| SMALL-CAP GROWTH PROFUND ProFunds | 227 | 5.2K $ | 0.11 % | 0.00 % | as of Apr 30, 2026 ↗ |
| SMALL-CAP VALUE PROFUND ProFunds | 199 | 4.6K $ | 0.08 % | 0.00 % | as of Apr 30, 2026 ↗ |
| PROFUND VP SMALL CAP ProFunds | 190 | 4.4K $ | 0.04 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Russell 2000 Fund Rydex Series Funds | 169 | 3.9K $ | 0.03 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Acclivity Small Cap Value Fund NORTHERN LIGHTS FUND TRUST II | 147 | 3.4K $ | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
| SMALL-CAP PROFUND ProFunds | 137 | 3.1K $ | 0.04 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Columbia Research Enhanced Small Cap ETF Columbia ETF Trust I | 113 | 2.6K $ | 0.09 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Russell 2000 1.5x Strategy Fund Rydex Series Funds | 101 | 2.4K $ | 0.04 % | 0.00 % | as of Mar 31, 2026 ↗ |
| E*TRADE No Fee Total Market Index Fund E Trade Trust | 99 | 2.3K $ | 0.00 % | 0.00 % | as of Apr 30, 2026 ↗ |
| ProShares Hedge Replication ETF ProShares Trust | 65 | 1.5K $ | 0.01 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Avantis Total Equity Markets ETF American Century ETF Trust | 42 | 964.3 $ | 0.00 % | 0.00 % | as of Feb 28, 2026 ↗ |
| ProShares Russell 2000 Dynamic Buffer ETF ProShares Trust | 22 | 505.1 $ | 0.05 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Russell 2000(R) 1.5x Strategy Fund Rydex Variable Trust | 17 | 396.1 $ | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
| BOMBAY INVESTMENT OFFICE, S.A., SICAV SINGULAR ASSET MANAGEMENT, SGIIC, S.A. | 85.1K € | 0.04 % | as of Dec 31, 2025 ↗ | ||
| GESTION BOUTIQUE VII, FI GESTION BOUTIQUE VII / SYSTEMATIC VALUE INVESTING US MARKETS ANDBANK WEALTH MANAGEMENT, SGIIC, S.A.U. | 20.4K € | 2.09 % | as of Dec 31, 2025 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| Invesco Pharmaceuticals ETF Invesco Exchange-Traded Fund Trust | 2.88 % | as of Apr 30, 2026 ↗ |
| RIVER OAK DISCOVERY FUND Oak Associates Funds | 2.67 % | as of Apr 30, 2026 ↗ |
| WPG Partners Select Small Cap Value Fund RBB Fund, Inc. | 2.64 % | as of Feb 28, 2026 ↗ |
| ETC 6 Meridian Small Cap Equity ETF EXCHANGE TRADED CONCEPTS TRUST | 2.33 % | as of Feb 28, 2026 ↗ |
| GESTION BOUTIQUE VII, FI GESTION BOUTIQUE VII / SYSTEMATIC VALUE INVESTING US MARKETS ANDBANK WEALTH MANAGEMENT, SGIIC, S.A.U. | 2.09 % | as of Dec 31, 2025 ↗ |
| State Street(R) SPDR(R) S&P(R) Pharmaceuticals ETF SPDR SERIES TRUST | 1.99 % | as of Mar 31, 2026 ↗ |
| PROFUND VP PHARMACEUTICALS ProFunds | 1.91 % | as of Mar 31, 2026 ↗ |
| JAMES SMALL CAP FUND JAMES ADVANTAGE FUNDS | 1.66 % | as of Mar 31, 2026 ↗ |
| JAMES MICRO CAP FUND JAMES ADVANTAGE FUNDS | 1.63 % | as of Mar 31, 2026 ↗ |
| Royce Capital Fund - Small-Cap Portfolio ROYCE CAPITAL FUND | 1.49 % | as of Mar 31, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Shareholders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q2 | 324 | +15 | 34,012,374 | +3.6 % |
| 2026Q1 | 309 | +6 | 32,835,592 | +5.4 % |
| 2025Q4 | 303 | -7 | 31,143,581 | -5.0 % |
| 2025Q3 | 310 | +8 | 32,794,743 | +5.6 % |
| 2025Q2 | 302 | +20 | 31,047,523 | -11.0 % |
| 2025Q1 | 282 | -10 | 34,885,512 | +2.5 % |
| 2024Q4 | 292 | +6 | 34,029,696 | -10.3 % |
| 2024Q3 | 286 | +2 | 37,937,981 | +0.3 % |
| 2024Q2 | 284 | +15 | 37,839,393 | +7.0 % |
| 2024Q1 | 269 | -3 | 35,349,947 | +3.0 % |
| 2023Q4 | 272 | 34,305,245 |
Institutional managers
277 managers declare this company to the SEC (Form 13F). The table shows the 25 largest.
| Manager | Shares | Value | |
|---|---|---|---|
| BlackRock, Inc. | 11,307,845 | 263.5M $ | as of Mar 31, 2026 |
| DIMENSIONAL FUND ADVISORS LP | 4,436,427 | 103.4M $ | as of Mar 31, 2026 |
| RENAISSANCE TECHNOLOGIES LLC | 4,055,632 | 94.5M $ | as of Mar 31, 2026 |
| STATE STREET CORP | 3,060,377 | 71.3M $ | as of Mar 31, 2026 |
| MILLENNIUM MANAGEMENT LLC | 2,279,451 | 53.1M $ | as of Mar 31, 2026 |
| Sarissa Capital Management LP | 2,130,950 | 49.7M $ | as of Mar 31, 2026 |
| SYSTEMATIC FINANCIAL MANAGEMENT LP | 2,024,082 | 47.2M $ | as of Mar 31, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | 1,929,718 | 45M $ | as of Mar 31, 2026 |
| AMERICAN CENTURY COMPANIES INC | 1,910,021 | 44.5M $ | as of Mar 31, 2026 |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 1,887,570 | 44M $ | as of Mar 31, 2026 |
| Boston Partners | 1,718,867 | 40M $ | as of Mar 31, 2026 |
| BANK OF AMERICA CORP /DE/ | 1,619,994 | 37.7M $ | as of Mar 31, 2026 |
| GOLDMAN SACHS GROUP INC | 1,593,383 | 37.1M $ | as of Mar 31, 2026 |
| MARSHALL WACE, LLP | 1,504,411 | 35.1M $ | as of Mar 31, 2026 |
| TWO SIGMA INVESTMENTS, LP | 1,484,264 | 34.6M $ | as of Mar 31, 2026 |
| MORGAN STANLEY | 1,310,750 | 30.5M $ | as of Mar 31, 2026 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 1,163,713 | 27.1M $ | as of Mar 31, 2026 |
| ROYCE & ASSOCIATES LP | 1,061,448 | 24.7M $ | as of Mar 31, 2026 |
| DEUTSCHE BANK AG\ | 908,067 | 21.2M $ | as of Mar 31, 2026 |
| Invesco Ltd. | 904,282 | 21.1M $ | as of Mar 31, 2026 |
| DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main | 892,336 | 20.8M $ | as of Mar 31, 2026 |
| Qube Research & Technologies Ltd | 786,107 | 18.3M $ | as of Mar 31, 2026 |
| NORTHERN TRUST CORP | 774,303 | 18M $ | as of Mar 31, 2026 |
| Man Group plc | 744,791 | 17.4M $ | as of Mar 31, 2026 |
| Nuveen, LLC | 620,482 | 14.5M $ | as of Mar 31, 2026 |
Declared shareholders of Innoviva Inc
There is 1 beneficial ownership filing. These stakes do not add up. An asset manager that files includes its own funds, which already appear among the funds on this page.
| Shareholder | Declared stake | Shares | |
|---|---|---|---|
| Vanguard Portfolio Management | 5.79 % | 4,288,063 | as of Mar 31, 2026 · SCHEDULE 13G |
Funds holding the debt of Innoviva Inc
4 funds declare 4 bond lines of this company. The amount is the one the fund files. It is not a share of the debt, because no regulator publishes the amount outstanding in open access.
| Fund | Bond lines | Value | |
|---|---|---|---|
| Calamos Market Neutral Income Fund | 1 | 10.8M $ | as of Apr 30, 2026 |
| iShares Convertible Bond ETF | 1 | 4.6M $ | as of Apr 30, 2026 |
| Virtus Global Allocation Fund | 1 | 43.2K $ | as of Mar 31, 2026 |
| Virtus Newfleet Multi-Sector Bond ETF | 1 | 33.7K $ | as of Apr 30, 2026 |
Cite this page
Titelia. "Fund shareholders of Innoviva Inc". https://titelia.com/en/stocks/innoviva-inc-US45781M1018